Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$29.69 n/a | n/a%
09/26/16 - 04:00 PM ET
Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013
Assets
Cash and Equivalents 158.23M 150.39M 39.55M
Receivables 1.56M 4.23M 385.00K
Inventories 0.00 0.00 0.00
Other Current Assets 2.80M 3.97M 0.00
Total Current Assets 197.39M 179.14M 45.68M
Property, Plant & Equipment, Gross 14.02M 5.76M 2.37M
Accumulated Depreciation & Depletion 3.52M 1.29M 625.00K
Property, Plant & Equipment, Net 10.50M 4.47M 1.74M
Intangibles 2.62M 2.62M 0.00
Other Non-Current Assets 931.00K 50.00K 27.00K
Total Non-Current Assets 15.00M 8.09M 1.77M
Liabilities & Shareholder Equity
Total Assets 212.38M 187.22M 47.45M
Accounts Payable 29.50M 13.79M 3.69M
Short Term Debt 0.00 0.00 3.09M
Other Current Liabilities 1.44M 5.76M 24.27M
Total Current Liabilities 106.02M 51.78M 53.70M
Long Term Debt 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 113.30M 68.68M 36.13M
Minority Interest -678.00K -44.00K 0.00
Total Non-Current Liabilities 112.57M 68.64M 90.82M
Total Liabilities 218.59M 120.42M 144.52M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity -6.21M 66.80M -97.08M
Common Par 4.00K 3.00K 1.00K
Additional Paid In Capital 404.18M 254.05M 2.51M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -409.99M -186.72M -99.59M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -401.00K -525.00K 0.00
Total Capitalization -6.21M 66.80M -97.08M
Total Equity -6.21M 66.80M -97.08M
Total Liabilities & Stock Equity 212.38M 187.22M 47.45M
Total Common Shares Outstanding 39.01M 33.26M 32.05M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 37.12M 8.19M 14.69M
Diluted Weighted Shares Outstanding 37.12M 8.19M 14.69M
Number of Employees 109 66 NA
Number of Part-Time Employees 0 0 NA

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter